Live Breaking News & Updates on Delhi Director Randeep

Stay updated with breaking news from Delhi director randeep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Irrational plasma use could trigger virulent Covid variants: Scientists warn PM's adviser : The Tribune India


2577
Aditi Tandon
New Delhi, May 11
Top Indian scientists and clinicians on Monday wrote an open letter to government Covid strategists demanding the removal of convalescent plasma therapy from national Covid clinical protocols and warned against possibilities of plasma use triggering virulent Covid variants while being of no clinical benefit among Covid patients.
“Current research evidence unanimously indicates there is no benefit offered by convalescent plasma for treatment of COVID-19. However, it continues to be prescribed rampantly in hospitals across India. Families of patients run from pillar-to-post for getting plasma, which is in short supply and black marketing is common. Some very early evidence indicated a possible association between emergence of variants with lower susceptibility to neutralizing antibodies in immunosuppressed people given plasma therapy. This raises the possibility of more virulent strains developing due to irrational use of plasma ....

United States , New Delhi , K Vijay Raghvan , Gautam Menon , Amar Jesani , Aditi Tandon , Oomen John , Shahid Jameel , Gagandeep Kang , Randeep Guleria , Balram Bhargava , National Institutes Of Health , Tribune News Service , Delhi Director Randeep , Indian Journal , Medical Ethics Amar Jesani , National Institutes , Recovery Trial , Plasmar Trial , ஒன்றுபட்டது மாநிலங்களில் , புதியது டெல்ஹி , கே விஜய் ராகவன் , கௌதம் மேனன் , அமர் ஜேசனி , ஷாஹித் ஜமீல் , ககந்டீப் காங் ,